A compound having the general structure shown in Formula I:
or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
具有式 I 所示一般结构的化合物:
或其药学上可接受的盐和/或溶解物,可用于治疗由 NK1 受体介导的疾病或病症,例如各种生理紊乱、症状或疾病,包括呃逆、抑郁、焦虑和咳嗽。